Free Newsletter
Australia approves a new bird flu vaccine
Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an outbreak. The vaccine will only be used in the event of a pandemic.
Australian government officials appeared to be particularly pleased that they could stockpile a vaccine developed inside the country. According to CSL, Panvax can be adjusted to provide protection against any emerging pandemic. Experts note that the bird flu virus will need to mutate into a new strain in order to spread swiftly among people.
- read the story in the Herald-Sun
More stories about undefined
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
